Physician profile
Michael C Speck
NPI 1881733897
$4,981.97
in general payments reported to CMS, 2019-2025
44 companies · $729 in 2025
The $729 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,278 · 2020: $518 · 2021: $579 · 2022: $794 · 2023: $565 · 2024: $521 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,732 · Education: $82.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,731.85 |
| Education | $82.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,199.13 | 2019-2025 | Speedicath, Titan |
| Astellas Pharma US INC | $491.23 | 2019-2025 | Xtandi |
| Sanara Medtech INC. | $294.20 | 2020 | |
| Sumitomo Pharma America, INC. | $293.77 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $285.44 | 2021-2025 | Urolift, Barrigel |
| Urovant Sciences INC | $231.17 | 2021-2022 | |
| Innovation Technologies INC | $223.17 | 2022-2024 | Irrisept |
| Abbvie INC. | $171.60 | 2019-2024 | Botox |
| Boston Scientific Corporation | $165.18 | 2019-2025 | Lithovue, Lumenis Pulse 120h |
| Cook Medical LLC | $138.75 | 2019-2024 | Cook |
| Progenics Pharmaceuticals, INC. | $132.53 | 2025 | |
| Avanos Medical | $115.43 | 2021 | |
| Janssen Biotech, INC. | $111.80 | 2019-2022 | |
| Allergan, INC. | $73.44 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $71.06 | 2023 | Prolaris |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $70.88 | 2022-2024 | Gentlecath Glide |
| Tolmar, INC. | $68.65 | 2025 | Jatenzo, Eligard |
| Axonics, INC. | $66.22 | 2020-2023 | Axonics |
| Urogen Pharma, INC. | $52.62 | 2024-2025 | |
| Neotract INC. | $51.37 | 2019-2020 | |
| Cycle Pharmaceuticals INC | $50.97 | 2025 | Venxxiva |
| Endo Pharmaceuticals INC. | $50.93 | 2019-2023 | Aveed, Xiaflex |
| Intuitive Surgical, INC. | $49.86 | 2019 | |
| Amgen INC. | $48.15 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $46.84 | 2024-2025 | Exparel, Iovera |
| Endo USA, INC. | $39.18 | 2024-2025 | Xiaflex |
| Medtronic, INC. | $33.26 | 2025 | Interstim |
| Acerus Pharmaceuticals Corporation | $31.42 | 2021-2022 | |
| Stryker Corporation | $30.93 | 2023 | Iris |
| Karl Storz Endoscopy-America | $27.89 | 2024 | N.A. |
| Pfizer INC. | $27.31 | 2019 | |
| Procept Biorobotics Corporation | $26.52 | 2025 | |
| Calyxo, INC. | $25.02 | 2025 | Cvac Aspiration System |
| Lexington Medical, INC. | $21.50 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Immunitybio, INC. | $20.77 | 2025 | |
| Hollister Incorporated | $19.27 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $19.24 | 2025 | Lynparza |
| Dendreon Pharmaceuticals LLC | $18.77 | 2025 | Provenge |
| Travere Therapeutics, INC. | $17.73 | 2019 | |
| Halozyme INC | $17.48 | 2023 | |
| Olympus America INC. | $17.43 | 2025 | Itind System |
| Antares Pharma, INC. | $14.55 | 2023 | Tlando, Xyosted, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $13.56 | 2024 | |
| Clarus Therapeutics INC. | $5.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Speck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.